Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Defazio

Showing results (151-160 of 248) with videos related to

Pageof 25
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasmJordi Clarimon, Francesco Brancati, Elizabeth Peckham, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 29, 2025
Clinical diagnosis and communication in functional neurological disorders: a survey among Italian neurologistsVittorio Velucci, Angela Sandri, Mario Zappia, et al.
Cellular Signalling|May 22, 2002
Interferon beta-1a counteracts effects of activation on the expression of G-protein-coupled receptor kinases 2 and 3, beta-arrestin-1, and regulators of G-protein signalling 2 and 16 in human mononuclear leukocytesMaurizio Giorelli, Paolo Livrea, Giovanni Defazio, et al.
Journal of Neurology|April 9, 2025
The natural history of body-first versus brain-first Parkinson's disease subtypesVittorio Velucci, Angelo Fabio Gigante, Giovanni Iliceto, et al.
Clinical Chemistry and Laboratory Medicine|June 17, 2006
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesiasStefano Zoccolella, Paolo Lamberti, Giovanni Iliceto, et al.
Neurogenetics|May 28, 2020
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effectMarta Melis, Andrea Molari, Gianluca Floris, et al.
Parkinsonism & Related Disorders|April 29, 2022
Neurofilament assessment in patients with cervical dystoniaGina Ferrazzano, Maria Antonella Zingaropoli, Matteo Costanzo, et al.
Hellenic Journal of Nuclear Medicine|December 15, 2015
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's diseaseArtor Niccoli Asabella, Angelo Fabio Gigante, Cristina Ferrari, et al.
Computers in Biology and Medicine|August 7, 2019
A neural network-based software to recognise blepharospasm symptoms and to measure eye closure timeGianpaolo F Trotta, Roberta Pellicciari, Antonio Boccaccio, et al.
Recenti Progressi in Medicina|September 18, 2013
[Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia]Artor Niccoli Asabella, Marilena Ruggeri, Domenico Rubini, et al.
Pageof 25

Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Assessing the role of DRD5 and DYT1 in two different case-control series with primary blepharospasmJordi Clarimon, Francesco Brancati, Elizabeth Peckham, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 29, 2025
Clinical diagnosis and communication in functional neurological disorders: a survey among Italian neurologistsVittorio Velucci, Angela Sandri, Mario Zappia, et al.
Cellular Signalling|May 22, 2002
Interferon beta-1a counteracts effects of activation on the expression of G-protein-coupled receptor kinases 2 and 3, beta-arrestin-1, and regulators of G-protein signalling 2 and 16 in human mononuclear leukocytesMaurizio Giorelli, Paolo Livrea, Giovanni Defazio, et al.
Journal of Neurology|April 9, 2025
The natural history of body-first versus brain-first Parkinson's disease subtypesVittorio Velucci, Angelo Fabio Gigante, Giovanni Iliceto, et al.
Clinical Chemistry and Laboratory Medicine|June 17, 2006
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesiasStefano Zoccolella, Paolo Lamberti, Giovanni Iliceto, et al.
Neurogenetics|May 28, 2020
Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effectMarta Melis, Andrea Molari, Gianluca Floris, et al.
Parkinsonism & Related Disorders|April 29, 2022
Neurofilament assessment in patients with cervical dystoniaGina Ferrazzano, Maria Antonella Zingaropoli, Matteo Costanzo, et al.
Hellenic Journal of Nuclear Medicine|December 15, 2015
Role of dopaminergic neurotransmission in pathophysiology of action tremor in Parkinson's diseaseArtor Niccoli Asabella, Angelo Fabio Gigante, Cristina Ferrari, et al.
Computers in Biology and Medicine|August 7, 2019
A neural network-based software to recognise blepharospasm symptoms and to measure eye closure timeGianpaolo F Trotta, Roberta Pellicciari, Antonio Boccaccio, et al.
Recenti Progressi in Medicina|September 18, 2013
[Correlation between cognitive impairment and plasma levels of clusterin/ApoJ in Parkinson disease patients not affected by dementia]Artor Niccoli Asabella, Marilena Ruggeri, Domenico Rubini, et al.
Pageof 25